Skip Intro

Avalanche Biotech

Deerfield invested in Avalanche Biotech as part of a $55 million Series B financing. Avalanche is a biotechnology company that develops gene therapy based technologies to the eye to treat wet age-related macular degeneration, as well as other ophthalmologic disorders.